Literature DB >> 24030970

Energy metabolism characterization of a novel cancer stem cell-like line 3AB-OS.

Roberta Palorini1, Giuseppina Votta, Chiara Balestrieri, Andrea Monestiroli, Sandro Olivieri, Renza Vento, Ferdinando Chiaradonna.   

Abstract

Cancer stem cells (CSC) have a central role in driving tumor growth. Since metabolism is becoming an important diagnostic and therapeutic target, characterization of CSC line energetic properties is an emerging need. Embryonic and adult stem cells, compared to differentiated cells, exhibit a reduced mitochondrial activity and a stronger dependence on aerobic glycolysis. Here, we aimed to comparatively analyze bioenergetics features of the human osteosarcoma 3AB-OS CSC-like line, and the parental osteosarcoma MG63 cells, from which 3AB-OS cells have been previously selected. Our results suggest that 3AB-OS cells depend on glycolytic metabolism more strongly than MG63 cells. Indeed, growth in glucose shortage or in presence of galactose or pyruvate (mitochondrial specific substrates) leads to a significant reduction of their proliferation compared to MG63 cells. Accordingly, 3AB-OS cells show an increased expression of lactate dehydrogenase A (LDHA) and a larger accumulation of lactate in the culture medium. In line with these findings 3AB-OS cells as compared to MG63 cells present a reduced mitochondrial respiration, a stronger sensitivity to glucose depletion or glycolysis inhibition and a lessened sensitivity to oxidative phosphorylation inhibitors. Additionally, in contrast to MG63 cells, 3AB-OS display fragmented mitochondria, which become networked as they grow in glucose-rich medium, while almost entirely loose these structures growing in low glucose. Overall, our findings suggest that 3AB-OS CSC energy metabolism is more similar to normal stem cells and to cancer cells characterized by a glycolytic anaerobic metabolism.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  CANCER METABOLISM; CANCER STEM CELLS; WARBURG EFFECT

Mesh:

Year:  2014        PMID: 24030970     DOI: 10.1002/jcb.24671

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  60 in total

1.  Intraperitoneal delivery of a novel liposome-encapsulated paclitaxel redirects metabolic reprogramming and effectively inhibits cancer stem cells in Taxol(®)-resistant ovarian cancer.

Authors:  Yao-An Shen; Wai-Hou Li; Po-Hung Chen; Chun-Lin He; Yen-Hou Chang; Chi-Mu Chuang
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

2.  Ovarian tumor-initiating cells display a flexible metabolism.

Authors:  Angela S Anderson; Paul C Roberts; Madlyn I Frisard; Matthew W Hulver; Eva M Schmelz
Journal:  Exp Cell Res       Date:  2014-08-27       Impact factor: 3.905

3.  Loss of fructose-1,6-bisphosphatase induces glycolysis and promotes apoptosis resistance of cancer stem-like cells: an important role in hexavalent chromium-induced carcinogenesis.

Authors:  Jin Dai; Yanli Ji; Wei Wang; Donghern Kim; Leonard Yenwong Fai; Lei Wang; Jia Luo; Zhuo Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-15       Impact factor: 4.219

Review 4.  Targeting cancer stem cells from a metabolic perspective.

Authors:  Yao-An Shen; Siao-Cian Pan; I Chu; Ruo-Yun Lai; Yau-Huei Wei
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-26

Review 5.  The metabolic state of cancer stem cells-a valid target for cancer therapy?

Authors:  Erina Vlashi; Frank Pajonk
Journal:  Free Radic Biol Med       Date:  2014-11-10       Impact factor: 7.376

Review 6.  Metabolic features of cancer stem cells: the emerging role of lipid metabolism.

Authors:  Rita Mancini; Alessia Noto; Maria Elena Pisanu; Claudia De Vitis; Marcello Maugeri-Saccà; Gennaro Ciliberto
Journal:  Oncogene       Date:  2018-02-15       Impact factor: 9.867

Review 7.  Metabolic regulation of glioma stem-like cells in the tumor micro-environment.

Authors:  Tom M Thomas; John S Yu
Journal:  Cancer Lett       Date:  2017-07-22       Impact factor: 8.679

8.  Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.

Authors:  Yao-An Shen; Chia-Yu Wang; Yi-Tao Hsieh; Yann-Jang Chen; Yau-Huei Wei
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 9.  Harnessing the apoptotic programs in cancer stem-like cells.

Authors:  Ying-Hua Wang; David T Scadden
Journal:  EMBO Rep       Date:  2015-08-07       Impact factor: 8.807

Review 10.  Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance.

Authors:  Plabon Kumar Das; Suja Pillai; Md Abdur Rakib; Jahan Ara Khanam; Vinod Gopalan; Alfred K Y Lam; Farhadul Islam
Journal:  Stem Cell Rev Rep       Date:  2020-04       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.